$8.58
0.111.28%
Last update: Sep 4, 8:51 AM
Cormedix Inc
CRMDNASDAQ
Cormedix Earnings & Forecasts
Cormedix (CRMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Cormedix Guidance
Cormedix (CRMD) last issued guidance on August 13, 2026 for fiscal year 2026. The company guided revenue in the range of $325M - $345M for the period.
Compared to prior guidance, Cormedix maintained its revenue forecast from a prior range of $325M - $345M.
Cormedix has issued 12 guidance updates between January 7, 2025 and August 13, 2026. During this period, the company raised its outlook 5 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.24 | $0.33 | $0.83 | $0.57 |
| Actual | $0.29 | $0.43 | $0.61 | $0.57 |
| Surprise | +20.8% | +30.3% | -26.5% | 0.00% |
| Revenue | ||||
| Estimate | $95.8M | $105.9M | $127.1M | $86.0M |
| Actual | $101.9M | $127.4M | $128.6M | $104.3M |
| Surprise | +6.42% | +20.3% | +1.15% | +21.2% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.09 | $-0.12 |
| Revenue | ||
| Consensus | $53.4M | $54.0M |
